1. Trastuzumab deruxtecan in previously treated HER2-positive gastric cancer;Shitara;N Engl J Med,2020
2. Final overall survival for KEYNOTE-002: pembrolizumab (pembro) versus investigator-choice chemotherapy (chemo) for ipilimumab (ipi)-refractory melanoma;Hamid;Ann Oncol,2016
3. Medicines in development. PhRMA Org. (n.d.). Available from: 〈https://phrma.org/Scientific-Innovation/In-The-Pipeline/Medicines-in-Development〉. [Retrieved 16 June 2022].
4. Mikulic M. (2020, February 5). Oncology clinical trial starts globally 2000–2018. Statista. Available from: 〈https://www.statista.com/statistics/1092600/oncology-clinical-trial-starts-worldwide/〉. [Retrieved 16 June 2022].
5. The changing landscape of phase I trials in oncology;Wong;Nat Rev Clin Oncol,2016